BioVascular

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

12230 El Camino Real Ste 100, San Diego,...

Phone Number

(858) 455-5000

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About BioVascular

BioVascular Inc. is a privately held biotechnology company that develops drugs and devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors associated with cardiovascular morbidity and mortality. BioVascular's lead product, saratin, is a polypeptide produced by recombinant means in yeast. This product was licensed from Merck, KGaA in 2005. BioVascular began human clinical trials of saratin for hemodialysis graft access in late 2006 and will begin human trials in the treatment of peripheral artery grafts in early 2007. BioVasculars second product utilizes a novel mechanism for reduction of a recently defined cardiovascular risk factor. This product will enter human studies in mid 2007.Explore more
BioVascular's Social MediaPopular SearchesBioVascular IncBio Vascular IncBioVascBiovasc IncEvascular IncSIC Code 28,283NAICS Code 32,325Show more

Is BioVascular your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BioVascular is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BioVascular is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioVascular.

BioVascular financials insights

Gather financial insights about BioVascular, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2005

Series A

$4M

2007

Series B

$8.1M

2008

Series C

$10.9M

See All BioVascular's Financials Insights

BioVascular Tech Stack

Top Manufacturing Companies

Frequently Asked Questions Regarding BioVascular

What is BioVascular's official website?
BioVascular's official website is www.biovascularinc.com
What is BioVascular's Revenue?
BioVascular's revenue is <$5 Million
What is BioVascular's SIC code?
BioVascular's SIC: 28,283
What is BioVascular's NAICS code?
BioVascular's NAICS: 32,325
How many employees does BioVascular have?
BioVascular has 1-10 employees
What industry does BioVascular belong to?
BioVascular is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does BioVascular use?
Some of the popular technologies that BioVascular uses are: GoDaddy SSL Certificates, Amazon Web Hosting, Apache HTTP Server
How do I contact BioVascular?
BioVascular contact info: Phone number: (858) 455-5000 Website: www.biovascularinc.com
What does BioVascular do?

BioVascular Inc. is a privately held biotechnology company that develops drugs and devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors associated with cardiovascular morbidity and mortality. BioVascular's lead product, saratin, is a polypeptide produced by recombinant means in yeast. This p... roduct was licensed from Merck, KGaA in 2005. BioVascular began human clinical trials of saratin for hemodialysis graft access in late 2006 and will begin human trials in the treatment of peripheral artery grafts in early 2007. BioVasculars second product utilizes a novel mechanism for reduction of a recently defined cardiovascular risk factor. This product will enter human studies in mid 2007.Read More

What are BioVascular social media links?
BioVascular Linkedin page BioVascular Facebook page
Who invested in BioVascular?
BioVascular has 5 investors including Domain Associates, BB Biotech Ventures and Merck KGaA.
Is BioVascular a public company?
BioVascular is private company therefore does not currently have an official ticker symbol
See more information about BioVascular

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.